FDA Panel Backs COVID-19 Boosters Only for Elderly, High Risk

Published on September 19, 2021

Dealing the White House a stinging setback, a government advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots across the board, and instead endorsed the extra dose only for those who are 65 or older or run a high risk of severe…

Read Full Article (External Site)